Treatment options for low-risk prostate cancer
World J Urol
.
2022 Nov;40(11):2827-2828.
doi: 10.1007/s00345-022-04144-7.
Epub 2022 Sep 13.
Authors
Yuxuan Song
1
,
Tao Xu
2
Affiliations
1
Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
2
Department of Urology, Peking University People's Hospital, Beijing, 100044, China. xutao@pkuph.edu.cn.
PMID:
36098761
DOI:
10.1007/s00345-022-04144-7
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Male
Prostatectomy
Prostatic Neoplasms* / surgery
Grants and funding
2018YFA0902802/Key Technologies Research and Development Program
2022-4-4087/Capital Health Research and Development of Special Fund